transparent gif


Ej inloggad.

Göteborgs universitets publikationer

The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women.

Författare och institution:
Celina Franco Ramos (Institutionen för medicin, avdelningen för invärtesmedicin); Josef Koranyi (Institutionen för medicin, avdelningen för invärtesmedicin); John Brandberg (Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi); Lars Lönn (Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi); BK Bengtsson (-); Johan Svensson (Institutionen för medicin, avdelningen för invärtesmedicin); Gudmundur Johannsson (Institutionen för medicin, avdelningen för invärtesmedicin)
Publicerad i:
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 19 ( 2 ) s. 112–120
Artikel, refereegranskad vetenskaplig
Sammanfattning (abstract):
CONTEXT: Women with severe growth hormone (GH) deficiency have a less marked response to GH replacement than men. This has mostly been attributed to the attenuating effects of oestrogen replacement therapy. OBJECTIVE: To study gender related differences in the response to GH treatment in men and postmenopausal women. METHODS: Fifteen men and 15 age- and BMI-matched women with abdominal obesity (mean age: 58; range 51-64 years) were treated for one year with similar doses (0.47 vs. 0.51mg/day) of GH. All women were postmenopausal not receiving oestrogen treatment. Insulin sensitivity was assessed using a hyperinsulinemic euglycemic clamp and body composition by computed tomography (CT) scans and from total body potassium, K(40). RESULTS: Men and women were comparable at baseline in terms of waist circumference, IGF-1 and lipid levels. After one year of GH treatment, there was a 18% reduction in visceral adipose tissue (VAT) in men and a 5% reduction in women (P=0.0001 men vs. women). Although the magnitude of the difference was small, men increased more in thigh muscle mass (P<0.0001 vs. women). A reduction in thigh intermuscular adipose tissue (IMAT) and diastolic blood pressure was seen only in men (both p<0.05 vs. baseline). A decrease in LDL cholesterol, and an increase in serum insulin, was observed only in women (both p<0.05 vs. baseline). CONCLUSION: Low dose GH treatment reduced VAT more markedly in men as compared with women. As all women were postmenopausal and oestrogen-deficient, this gender difference in responsiveness was not due to an antagonistic effect of oestrogen on peripheral GH action.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
Growth hormone, Abdominal obesity, Gender difference, Metabolic syndrome, Regional adipose tissue distribution, Insulin sensitivity, Adipokines, Oestrogen, Androgens
Postens nummer:
Posten skapad:
2009-01-13 12:46
Posten ändrad:
2012-06-26 14:22

Visa i Endnote-format

Göteborgs universitet • Tel. 031-786 0000
© Göteborgs universitet 2007